TestmBankm-mPharmacology:mA mPatient-Centered mNursingmProcessmApproachm(9th mEdition, m2017)
PHARMACOLOGYm9THmE DITIONmMCCUISTIONmTEST mBANK
Thismismamsetmof mquestionsmto manswermthemquestionsmof mthemtextbook m"Pharmacology:mAmPatient-
CenteredmNursingmProcessmApproachm9thmEdition"mitmhelpsmyoumtombettermunderstandmthembook mcorrectl
y.
Getmthemrightmdosagemof mpharmacologymcontentmtomsucceedmonmthemNCLEXmandmasmamprofessionalmnu
rsemwithm"Pharmacology:mAmPatient-
CenteredmNursingmProcessmApproach,m9thmEdition".mUsingmamstreamlinedmprototype mapproachmandma
nmemphasismonmnursingmcare,mthismtextmmakesmitmeasymformtoday’smnursingmstudentsmto mbettermunderst
andmthemcomplicatedmsubjectmof mpharmacology.mThembook’smdetailedmchaptermonmdosagemcalculation,mt
hemnursingmprocessmframework mformdrugmtherapy,mstrongmQSENmfocus,mandmsummariesmof mprototypem
drugsmhelpmdelivermthemperfect.
,Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
Table of Contents
m m
Tablemof mContents Chapterm28:mPeptides,mAntimalarial,mand
Chapterm01:mDrugmDevelopmentmandm Anthelmintic
Ethical mConsiderations Chapterm29:mHIV-mandmAIDS-
Chapterm02:mPharmacokinetics,mPhar RelatedmDrugs
macodynamics,mandmPharmacogeneti Chapterm30:mTransplantmDrug
cs smChapterm31:mVaccinesmCha
Chapterm03:mCultural mConsiderationsm pterm32:mAnticancermDrugs
Chapterm04:mComplementarymandmAlte Chapterm33:mTargetedmTherapiesmtomTreatmC
rnativemTherapies ancer
Chapterm05:mPediatricmConsideration Chapterm34:mBiologicmResponsemModifie
smChapterm06:mGeriatricmConsideratio rs
nsmChapterm07:mDrugsminmSubstancem Chapterm35:mUppermRespiratorymDisor
UsemDisorder ders
Chapterm08:mThemNursingmProcessman Chapterm36:mLowermRespiratorymDisor
dmPatient-CenteredmCare ders
Chapterm09:mSafetymandmQualitymChap Chapterm37:mCardiacmGlycosides,mAnti
term10:mDrugmAdministrationmChapterm1 anginals,mandmAntidysrhythmicsmChap
1:mDrugmCalculationsmChapterm12:mFlui term38:mDiuretics
dmVolumemandmElectrolytes Chapterm39:mAntihypertensive
Chapterm13:mVitamin mandmMineralmRepl Chapterm40:mAnticoagulants,mAntiplatele
acement ts,mandmThrombolyticsmChapterm41:mAnti
Chapterm14:mNutritionalmSupportmChap hyperlipidemicsmandmPeripheral mVasodil
term15:mAdrenergicmAgonistsmandmAnta ators
gonists Chapterm42:mGastrointestinal mTractmDi
Chapterm16:mCholinergicmAgonistsman sorders
dmAntagonists Chapterm43:mAntiulcermDrugsmChapt
Chapterm17:mStimulants erm44:mEyemandmEarmDisordersmCha
Chapterm18:mDepressantsmChapt pterm45:mDermatologicmDisordersmCh
erm19:mAntiseizuremDrugs apterm46:mPituitary,mThyroid,mParath
Chapterm20:mDrugsmformParkinsonismmand yroid,mandmAdrenalmDisordersmChapt
mAlzheimer'smDisease erm47:mAntidiabetics
Chapterm21:mDrugsmformNeuromuscular Chapterm48:mUrinarymDisordersmChapt
mDisordersmandmMusclemSpasmsmChap erm49:mPregnancymandmPretermmLabor
term22:mAntipsychoticsmandmAnxiolytics Chapterm50:mLabor,mDelivery,mandmPos
Chapterm23:mAntidepressantsmandmMoodm tpartum
Stabilizers Chapterm51:mNeonatalmandmNewbor
Chapterm24:mAntiinflammatories nmChapterm52:mWomen'smReproducti
Chapterm25:mAnalgesics vemHealth
Chapterm26:mAntibacterials Chapterm53:mMen'smReproductivemHealth mC
Chapterm27:mAntituberculars,mAntifungals, hapterm54:mSexuallymTransmittedmInfections
mandmAntivirals Chapterm55:mAdultmandmPediatric
,Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
EmergencymDrugs
, Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
Chapter 01: Drug Development and Ethical Considerations
m m m m m m
MULTIPLEmCHOICE
1. ThemnursemismpreparingmtomadministermamschedulemIIminjectablemdrugmandmismdrawingmupmhal
f mof mthemcontentsmof mamSingle-usemvial.mWhichmnursingmactionmismcorrect?
a. Ask manothermnursemtomobservemandmcosignmwastingmthemremainingmdrugmfrom mthemvial.
b. Keepmthemremainingmamountminmthempatient’smdrawermtomgivematmthemnextmdose.
c. Recordmthemamountmunusedminmthempatient’smmedicationmrecord.
d. Disposemof mthemvialmwithmthemremainingmdrugmintomamlockedmcollectionmb
ox.mANS:mA
SchedulemIImdrugsmaremcontrolledmsubstances,mandmallmmustmbemaccountedmfor.mWhenmwastingma
mportionmof mamdrug,manothermnursemshouldmobservemandmcosignmthatmamdrugmwasmwasted.
DIF:mCOGNITIVEmLEVEL:mApplyingm(Application)m
TOP:mNURSING mPROCESS:mNursingmIntervention
MSC:mNCLEX:mPhysiologicalmIntegrity:mPharmacologicalmandmParenteralmTherapies
2. Ampatientmismprescribedmammedicationmandmasksmthemnursemif mthemdrugmismavailableminmamgen
eric mform.mThemnursemunderstandsmthatmamgeneric mmedicationmwillmhavemamnamemthat
a. ismamregisteredmtrademark.
b. ismalwaysmcapitalized.
c. describesmthemdrugsmchemicalmstructure.
d. ismnon-
proprietary.mANS:mD
Themgeneric mnamemismthemofficial,mnon-
proprietary mnamemformamdrug.mThembrandmnamemismthemtrademark mnamemandmismalwaysmcapitalize
d.mThemchemicalmnamemdescribesmthemchemicalmstructuremof mthemdrug.
DIF:mCOGNITIVEmLEVEL:mUnderstandingm(Comprehension)
mTOP:mNURSING mPROCESS:mN/A
MSC:mNCLEX:mPhysiologicalmIntegrity:mPharmacologicalmandmParenteralmTherapies
3. Ampatientmreceivesmamprescriptionmonmwhichmthemprovidermhasmnotedmthatmamgeneric mmedicat
ionmmaymbemgiven.Thempatientmasksmthemnursemwhatmthismmeans.mWhatmwillmthemnursemtellmthe
mpatientmaboutmgeneric mdrugs?
a. They mcontainmthemsameminertmingredientsmasmbrand-namemdrugs.
b. They mhavemchemicalmstructuresmthatmaremidenticalmtomproprietary mdrugs.
c. They mtendmtombemlessmexpensivemthanmbrand-namemdrugs.
d. They mundergomextensivemtestingmbeforemthey maremmarkete
d.mANS:mC
Generic mdrugsmaremapprovedmby mthemFDAmifmtheymaremprovedmtombembioequivalentmtomthembrand-
mnamemdrug.mThey mtendmtombemlessmexpensivembecausemmanufacturersmofmthesemdrugsmdomnotmh
avemtomdomthemextensivemtestingmrequiredmof mbrand-
namemdrugsmbeforemmarketing.mThey maremnotmidenticalmtombrand-
namemdrugsmandmoftenmhavemdifferentminertmingredients.
DIF:mCOGNITIVEmLEVEL:mApplyingm(Application)
TOP:mNURSING mPROCESS:mNursingmIntervention:mPatientmTeachingmM
SC:mNCLEX:mManagementmof mClientmCare
4. ThemnursemreviewsminformationmaboutmamdrugmandmnotesmtheminitialsmUSPmaftermthemdrugsmoffi
cialmname.mThemnursemunderstandsmthatmthismdesignationmindicatesmthemdrug
a. ismamcontrolledmsubstance.
PHARMACOLOGYm9THmE DITIONmMCCUISTIONmTEST mBANK
Thismismamsetmof mquestionsmto manswermthemquestionsmof mthemtextbook m"Pharmacology:mAmPatient-
CenteredmNursingmProcessmApproachm9thmEdition"mitmhelpsmyoumtombettermunderstandmthembook mcorrectl
y.
Getmthemrightmdosagemof mpharmacologymcontentmtomsucceedmonmthemNCLEXmandmasmamprofessionalmnu
rsemwithm"Pharmacology:mAmPatient-
CenteredmNursingmProcessmApproach,m9thmEdition".mUsingmamstreamlinedmprototype mapproachmandma
nmemphasismonmnursingmcare,mthismtextmmakesmitmeasymformtoday’smnursingmstudentsmto mbettermunderst
andmthemcomplicatedmsubjectmof mpharmacology.mThembook’smdetailedmchaptermonmdosagemcalculation,mt
hemnursingmprocessmframework mformdrugmtherapy,mstrongmQSENmfocus,mandmsummariesmof mprototypem
drugsmhelpmdelivermthemperfect.
,Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
Table of Contents
m m
Tablemof mContents Chapterm28:mPeptides,mAntimalarial,mand
Chapterm01:mDrugmDevelopmentmandm Anthelmintic
Ethical mConsiderations Chapterm29:mHIV-mandmAIDS-
Chapterm02:mPharmacokinetics,mPhar RelatedmDrugs
macodynamics,mandmPharmacogeneti Chapterm30:mTransplantmDrug
cs smChapterm31:mVaccinesmCha
Chapterm03:mCultural mConsiderationsm pterm32:mAnticancermDrugs
Chapterm04:mComplementarymandmAlte Chapterm33:mTargetedmTherapiesmtomTreatmC
rnativemTherapies ancer
Chapterm05:mPediatricmConsideration Chapterm34:mBiologicmResponsemModifie
smChapterm06:mGeriatricmConsideratio rs
nsmChapterm07:mDrugsminmSubstancem Chapterm35:mUppermRespiratorymDisor
UsemDisorder ders
Chapterm08:mThemNursingmProcessman Chapterm36:mLowermRespiratorymDisor
dmPatient-CenteredmCare ders
Chapterm09:mSafetymandmQualitymChap Chapterm37:mCardiacmGlycosides,mAnti
term10:mDrugmAdministrationmChapterm1 anginals,mandmAntidysrhythmicsmChap
1:mDrugmCalculationsmChapterm12:mFlui term38:mDiuretics
dmVolumemandmElectrolytes Chapterm39:mAntihypertensive
Chapterm13:mVitamin mandmMineralmRepl Chapterm40:mAnticoagulants,mAntiplatele
acement ts,mandmThrombolyticsmChapterm41:mAnti
Chapterm14:mNutritionalmSupportmChap hyperlipidemicsmandmPeripheral mVasodil
term15:mAdrenergicmAgonistsmandmAnta ators
gonists Chapterm42:mGastrointestinal mTractmDi
Chapterm16:mCholinergicmAgonistsman sorders
dmAntagonists Chapterm43:mAntiulcermDrugsmChapt
Chapterm17:mStimulants erm44:mEyemandmEarmDisordersmCha
Chapterm18:mDepressantsmChapt pterm45:mDermatologicmDisordersmCh
erm19:mAntiseizuremDrugs apterm46:mPituitary,mThyroid,mParath
Chapterm20:mDrugsmformParkinsonismmand yroid,mandmAdrenalmDisordersmChapt
mAlzheimer'smDisease erm47:mAntidiabetics
Chapterm21:mDrugsmformNeuromuscular Chapterm48:mUrinarymDisordersmChapt
mDisordersmandmMusclemSpasmsmChap erm49:mPregnancymandmPretermmLabor
term22:mAntipsychoticsmandmAnxiolytics Chapterm50:mLabor,mDelivery,mandmPos
Chapterm23:mAntidepressantsmandmMoodm tpartum
Stabilizers Chapterm51:mNeonatalmandmNewbor
Chapterm24:mAntiinflammatories nmChapterm52:mWomen'smReproducti
Chapterm25:mAnalgesics vemHealth
Chapterm26:mAntibacterials Chapterm53:mMen'smReproductivemHealth mC
Chapterm27:mAntituberculars,mAntifungals, hapterm54:mSexuallymTransmittedmInfections
mandmAntivirals Chapterm55:mAdultmandmPediatric
,Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
EmergencymDrugs
, Test mBank m-mPharmacology: mAmPatient-
Centered mNursing mProcess mApproachm(9thmEdition, m2017)
PHARMACOLOGYm9TH mEDITIONmMCC UISTION mTESTmBANK
Chapter 01: Drug Development and Ethical Considerations
m m m m m m
MULTIPLEmCHOICE
1. ThemnursemismpreparingmtomadministermamschedulemIIminjectablemdrugmandmismdrawingmupmhal
f mof mthemcontentsmof mamSingle-usemvial.mWhichmnursingmactionmismcorrect?
a. Ask manothermnursemtomobservemandmcosignmwastingmthemremainingmdrugmfrom mthemvial.
b. Keepmthemremainingmamountminmthempatient’smdrawermtomgivematmthemnextmdose.
c. Recordmthemamountmunusedminmthempatient’smmedicationmrecord.
d. Disposemof mthemvialmwithmthemremainingmdrugmintomamlockedmcollectionmb
ox.mANS:mA
SchedulemIImdrugsmaremcontrolledmsubstances,mandmallmmustmbemaccountedmfor.mWhenmwastingma
mportionmof mamdrug,manothermnursemshouldmobservemandmcosignmthatmamdrugmwasmwasted.
DIF:mCOGNITIVEmLEVEL:mApplyingm(Application)m
TOP:mNURSING mPROCESS:mNursingmIntervention
MSC:mNCLEX:mPhysiologicalmIntegrity:mPharmacologicalmandmParenteralmTherapies
2. Ampatientmismprescribedmammedicationmandmasksmthemnursemif mthemdrugmismavailableminmamgen
eric mform.mThemnursemunderstandsmthatmamgeneric mmedicationmwillmhavemamnamemthat
a. ismamregisteredmtrademark.
b. ismalwaysmcapitalized.
c. describesmthemdrugsmchemicalmstructure.
d. ismnon-
proprietary.mANS:mD
Themgeneric mnamemismthemofficial,mnon-
proprietary mnamemformamdrug.mThembrandmnamemismthemtrademark mnamemandmismalwaysmcapitalize
d.mThemchemicalmnamemdescribesmthemchemicalmstructuremof mthemdrug.
DIF:mCOGNITIVEmLEVEL:mUnderstandingm(Comprehension)
mTOP:mNURSING mPROCESS:mN/A
MSC:mNCLEX:mPhysiologicalmIntegrity:mPharmacologicalmandmParenteralmTherapies
3. Ampatientmreceivesmamprescriptionmonmwhichmthemprovidermhasmnotedmthatmamgeneric mmedicat
ionmmaymbemgiven.Thempatientmasksmthemnursemwhatmthismmeans.mWhatmwillmthemnursemtellmthe
mpatientmaboutmgeneric mdrugs?
a. They mcontainmthemsameminertmingredientsmasmbrand-namemdrugs.
b. They mhavemchemicalmstructuresmthatmaremidenticalmtomproprietary mdrugs.
c. They mtendmtombemlessmexpensivemthanmbrand-namemdrugs.
d. They mundergomextensivemtestingmbeforemthey maremmarkete
d.mANS:mC
Generic mdrugsmaremapprovedmby mthemFDAmifmtheymaremprovedmtombembioequivalentmtomthembrand-
mnamemdrug.mThey mtendmtombemlessmexpensivembecausemmanufacturersmofmthesemdrugsmdomnotmh
avemtomdomthemextensivemtestingmrequiredmof mbrand-
namemdrugsmbeforemmarketing.mThey maremnotmidenticalmtombrand-
namemdrugsmandmoftenmhavemdifferentminertmingredients.
DIF:mCOGNITIVEmLEVEL:mApplyingm(Application)
TOP:mNURSING mPROCESS:mNursingmIntervention:mPatientmTeachingmM
SC:mNCLEX:mManagementmof mClientmCare
4. ThemnursemreviewsminformationmaboutmamdrugmandmnotesmtheminitialsmUSPmaftermthemdrugsmoffi
cialmname.mThemnursemunderstandsmthatmthismdesignationmindicatesmthemdrug
a. ismamcontrolledmsubstance.